NYSE:EFXT

Enerflex (NYSE: EFXT) Price Target Raised by CIBC Amid Strong Financials

Font: Financial Modeling Prep  • May 08, 2026

Market Chart
  • Analyst firm CIBC has increased its price target for Enerflex, signaling a positive investment outlook for the company.
  • Enerflex demonstrated robust financial performance in Q1 2026, with significant revenue growth and strong profitability, highlighted by a record Return on Capital Employed (ROCE).
  • The company maintains a healthy financial position with a substantial operational backlog and effective debt management, reflected in its low net debt-to-EBITDA ratio.

Analyst firm CIBC has increased its price target for Enerflex (NYSE: EFXT) to $28.00 from its previous $25.00 target. Enerflex is a global company that supplies equipment and services for natural gas compression and processing. This upgrade follows the company's recent performance update, with the stock trading at $27.59 at the time of the announcement, reflecting a positive investment outlook.

The positive outlook is supported by strong first-quarter 2026 results, as highlighted by GlobeNewswire. Enerflex reported revenue of $584 million, an increase from $552 million in the same quarter last year. This revenue growth was driven by its Engineered Systems product line, though it was a decrease from the previous quarter's $627 million.

The company also shows strong profitability, achieving an adjusted EBITDA of $137 million. Enerflex reported a record Return on Capital Employed (ROCE) of 17.3%. ROCE is a key metric that shows how efficiently a company is using its money to generate profits, with a higher percentage indicating better financial performance.

Looking ahead, Enerflex has strong operational visibility with a combined backlog of $1.3 billion for two of its main segments. The company is also managing its debt well. It reported a bank-adjusted net debt-to-EBITDA ratio of 0.9x, which suggests a healthy financial position and low risk from its borrowings, reinforcing its long-term investment potential.

Market Overview
NIVF
NewGenIvf Group Limited
$0.13
27.72%
FNGR
FingerMotion, Inc.
$0.25
41.15%
AMOD
Alpha Modus Holdings, Inc.
$3.49
198.29%
FLUX
Flux Power Holdings, Inc.
$0.64
57.40%
SCNX
Scienture Holdings, Inc.
$0.16
-10.33%
SDEV
NovaBay Pharmaceuticals, Inc.
$7.48
104.37%
NKE
NIKE, Inc.
$33.87
-3.64%
NVDA
NVIDIA Corporation
$233.95
1.34%
QTEX
QTREX Quantum Ltd.
$1.10
40.20%
SPCX
Space Exploration Technologies Corp.
$158.96
7.35%